title: Next generation sequencing applications in cancer research.
authors.affiliation: Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA; Institute of Biomedical Technology, University of Tampere, Tampere 33014, Finland; Department of Epidemiology and Biostatistics, Tianjin Medical University, Cancer Institute and Hospital, Tianjin 300060, P.R. China. Electronic address: wzhang@mdanderson.org.
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
authors.forename: Matti
authors.initials: M
authors.lastname: Nykter
authors.forename: Kexin
authors.initials: K
authors.lastname: Chen
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000235:genetics*; D004252:DNA Mutational Analysis; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D023281:Genomics / Q000379:methods*; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D020411:Oligonucleotide Array Sequence Analysis; D010641:Phenotype; D057285:Precision Medicine; D011237:Predictive Value of Tests; D011379:Prognosis; D017422:Sequence Analysis, DNA
chemical_list: D014408:Biomarkers, Tumor